Kristen Gonzalez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kristen Gonzalez has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Dean C. Ripple
National Institute of Standards and Technology
1 shared publication - Mariam Khan
Analytical Sciences, AstraZeneca, Gaithersburg, MD
1 shared publication - Michael Carrier
Biomolecular Measurement Division, National Institute of Standards and Technology (NIST), Gaithersburg, MD
1 shared publication - Sonia Dragulin-Otto
Dosage Form Design and Development, AstraZeneca, Gaithersburg, MD; and
1 shared publication - Srivalli N. Telikepalli
NIST, Biomolecular Measurement Division, Gaithersburg, USA
1 shared publication
Latest Publications
- 17 June 2019
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 73 (5) , 418-432
Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals
Visible particles may potentially pose safety and efficacy concerns if inadvertently administered to patients; therefore, it is crucial to monitor and characterize these particles. These particles may be composed of proteinaceous and non-proteinaceous material. While particles made of non-proteinaceous material are unacceptable in drug products, proteinaceous particles may be acceptable on a case-by-case basis if characterized and shown not to pose quality, efficacy, and safety concerns. The focus of this manuscript is on the proteinaceous particles that may potentially form in some biopharmaceuticals. Monitoring and tracking proteinaceous particles in these biotherapeutics can be challenging but a universal protein-like particle standard might be able to help. The aim of this work is to evaluate abraded ethylene tetrafluoroethylene (ETFE) as a visible protein-like particle standard and demonstrate a semi-quantitative method to show how this surrogate can be used to effectively monitor proteinaceous particles during formulation and analytical development. Studies indicated that the ETFE particles in solution better mimic the appearance and behavior of protein particles than commonly used polystyrene microsphere standards and therefore could be a viable standard for visible proteinaceous particles. Such standards and the semi-quantitative method illustrated could be used effectively during development to non-destructively identify potential stability problems.
- 17 June 2019
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 73 (5) , 418-432
Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals
Visible particles may potentially pose safety and efficacy concerns if inadvertently administered to patients; therefore, it is crucial to monitor and characterize these particles. These particles may be composed of proteinaceous and non-proteinaceous material. While particles made of non-proteinaceous material are unacceptable in drug products, proteinaceous particles may be acceptable on a case-by-case basis if characterized and shown not to pose quality, efficacy, and safety concerns. The focus of this manuscript is on the proteinaceous particles that may potentially form in some biopharmaceuticals. Monitoring and tracking proteinaceous particles in these biotherapeutics can be challenging but a universal protein-like particle standard might be able to help. The aim of this work is to evaluate abraded ethylene tetrafluoroethylene (ETFE) as a visible protein-like particle standard and demonstrate a semi-quantitative method to show how this surrogate can be used to effectively monitor proteinaceous particles during formulation and analytical development. Studies indicated that the ETFE particles in solution better mimic the appearance and behavior of protein particles than commonly used polystyrene microsphere standards and therefore could be a viable standard for visible proteinaceous particles. Such standards and the semi-quantitative method illustrated could be used effectively during development to non-destructively identify potential stability problems.